-logo-1200x675.png){kind=logo}
Shares of CellaVision AB (publ) (OTCMKTS:CLVSF – Get Free Report) were down 13.2% during mid-day trading on Tuesday . The stock traded as low as $14.00 and last traded at $14.00. 1,740 shares were traded during trading, an increase of 207% from the average daily volume of 567 shares. The stock had previously closed at $16.1350.
CellaVision AB (publ) Stock Down 13.2%
The business has a fifty day moving average price of $13.90 and a 200-day moving average price of $15.57.
CellaVision AB (publ) Company Profile
CellaVision AB (publ), headquartered in Lund, Sweden, is a developer and manufacturer of advanced digital cell morphology solutions for clinical laboratories. The company’s systems automate the preparation, imaging and classification of blood and body fluid slides, enabling laboratory professionals to optimize workflow and improve diagnostic accuracy. CellaVision’s platform is designed to support a broad range of hematology analyses, including white blood cell differentiation, red blood cell morphology assessment and platelet evaluation.
The company’s core offering revolves around its digital microscopy instruments and proprietary software.
Featured Articles
- Five stocks we like better than CellaVision AB (publ)
- Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Apple’s Intel Deal Arrives at the Right Time for Its Stock
- Liquid Gold: The AI Cooling Retrofit Trade
- 3 Dividend Stocks Under $30 to Anchor Your Portfolio
Receive News & Ratings for CellaVision AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CellaVision AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
